.Alnylam is suspending better progression of a clinical-stage RNAi curative developed to alleviate S...
.Takeda has actually quit (PDF) a stage 2 test of danavorexton as a result of slow application, noti...
.Compass Pathways' adventure to stage 3 psychedelic depression information is taking longer than exp...
.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer last year for an enormous ...
.On the heels of a stage 3 succeed that neglected to excite clients, Ironwood Pharmaceuticals is bac...
.Don't cease Monte Rosa Rehabs now. The Boston-based biotech is actually enjoying after authorizing ...
.Accept to recently's Chutes & Ladders, our summary of notable leadership hirings, shootings and ...
.Commemorating his business's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang...
.AbbVie has actually come back to the source of its own antipsychotic powerhouse Vraylar trying to f...
.GenSight Biologics is actually full weeks far from running out of money. Once again. The biotech si...
.Monopar Therapeutics is bouncing back a medicine from the scrap heap of AstraZeneca's rare conditio...
.With brand-new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of experts wor...
.After creating a gene treatment alliance with Dyno Therapies in 2020, Roche is back for more.In a b...
.Lundbeck is reducing guide worth of its $250 million Abide Rehabs acquistion in reaction to stage 1...
.The integration of real-world information (RWD) right into method feasibility and also internet sit...
.At this year's Brutal Biotech Summit in Boston, we overtook forerunners in the biotech field who ha...
.Merck & Co. is setting down $30 million in advance to buy Yale spinout Modifi Biosciences, a dea...
.Alpha-9 Oncology has actually raised a $175 million series C cycle to stake its clinical-stage radi...
.Eye medication producer Ocuphire Pharma is actually getting gene treatment developer Piece Genetic ...
.Roche's persistent coughing course has actually faltered to a halt. The drugmaker, which axed the p...